CAMPTO (irinotecan hydrochloride) is indicated for the treatment of patients with advanced colorectal cancer: In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease.
As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.